SEATTLE — Since its approval by the U.S. Food and Drug Administration in 2006, the HPV vaccine has made considerable strides in preventing cervical and oropharyngeal, or throat cancers.

The first trial of an AI-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine ...